Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer's Disease/Cognition News
Q&A: Falls Decision Rule aims to reduce unnecessary CT scans in overcrowded EDs
A new clinical decision rule could help physicians determine which older ED patients who experienced a fall will require imaging, according to a study published in CMAJ.
Neighborhood disadvantage leads to poorer outcomes in those with focal epilepsy
ORLANDO — For a small cohort of individuals with focal epilepsy, “neighborhood disadvantage” was associated with poorer cognition including learning, memory and executive function, according to a poster.
Log in or Sign up for Free to view tailored content for your specialty!
Seizures associated with earlier decline to MCI in cognitively healthy adults
ORLANDO — In cognitively healthy adults, the presence of seizures predicted earlier change from normal cognition to mild cognitive impairment but was not associated with change from MCI to dementia. according to research.
Phase 2 study of Alzheimer’s disease psychosis therapy initiated
A phase 2 clinical trial has been initiated to evaluate the safety and efficacy of an inverse agonist for hallucinations and delusions associated with Alzheimer’s disease psychosis, according to the manufacturer.
FDA clears platform for non-invasive brain chemistry measurement
The FDA has cleared the use of a magnetic resonance spectroscopy platform to provide non-invasive measurement of brain chemistry and support diagnostic processes for a range of brain-related illnesses.
Early-onset heart disease drives risk for Alzheimer's disease, other dementias
Adults with a diagnosis of coronary heart disease before age 45 years are 36% more likely to develop dementia over 13 years of follow-up compared with those without a CHD diagnosis, data from the UK Biobank show.
Food insecurity associated with dementia risk
Food insecurity was linked to an increased risk for dementia and faster memory decline among older adults, according to a study published in JAMA Network Open.
Visceral abdominal fat in midlife linked to Alzheimer’s disease
Having a higher amount of visceral abdominal fat in middle age was associated with an increased risk for developing Alzheimer’s disease, according to research presented at the annual meeting of the Radiological Society of North America.
First patient enrolled in phase 2b trial of novel therapy for mild Alzheimer’s
The first patient has been enrolled in a European phase 2b clinical trial for AD04, a novel immunotherapy for the treatment of mild Alzheimer’s disease, according to the manufacturer.
Phase 3 clinical trial for investigational Alzheimer’s therapy expands to Asia, Europe
A South Korea-based life sciences company has announced expansion into the European Union, United Kingdom, Korea and China of its phase 3 study of an oral, investigational PDE5 inhibitor to treat early Alzheimer’s disease.
-
Headline News
Race, sex disparities persist in weight-loss surgery
January 16, 20253 min read -
Headline News
Survey reveals ‘disproportionate barriers’ to success among Latina physicians
January 16, 20252 min read -
Headline News
Study shows intentional strategies enhance recruitment, retainment of diverse populations
January 14, 20252 min read
-
Headline News
Race, sex disparities persist in weight-loss surgery
January 16, 20253 min read -
Headline News
Survey reveals ‘disproportionate barriers’ to success among Latina physicians
January 16, 20252 min read -
Headline News
Study shows intentional strategies enhance recruitment, retainment of diverse populations
January 14, 20252 min read